NCT07340541 2026-02-09EVOLVE-BDTUNC Lineberger Comprehensive Cancer CenterPhase 2 Not yet recruiting700 enrolled
NCT05867251 2025-11-19Study of AVZO-021 in Patients With Advanced Solid TumorsAvenzo Therapeutics, Inc.Phase 1/2 Recruiting430 enrolled
NCT03979508 2025-11-12Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerMayo ClinicPhase 2 Terminated26 enrolled